secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001140361-23-038095
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics effects 1-for-10 reverse stock split, effective August 4, 2023
-------------------------------------------------------------------------------

- Reverse stock split at ratio 1:10 effective 5:00 p.m. ET on August 4, 2023; trading on split-adjusted basis begins August 7, 2023.
- No fractional shares issued; stockholders otherwise entitled to fractional share receive cash in lieu.
- Proportionate adjustments to per-share exercise price and shares of stock options, RSUs, and warrants.
- Certificate of Elimination filed for Series A Preferred Stock (no shares outstanding), removing designation from charter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/0001140361-23-038095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/brhc20056936_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-038095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer